(CIDRAP News) A federal auditor has found that the US Food and Drug Administration's (FDA's) management of food inspections by state officials on the FDA's behalf has a number of weaknesses, including a failure in several states to ensure that inspections are completed and problems corrected.
(CIDRAP News) The US Government Accountability Office (GAO) today said drug shortages tripled over the past decade while in related news the Obama administration announced steps to address the problem.
Marcia Crosse, PhD, the GAO's director of healthcare, presented a GAO report today during testimony on prescription drug shortages before the Senate Committee on Health, Education, Labor, and Pensions (HELP).
(CIDRAP News) – Novartis's new cell-culture based influenza vaccine factory in North Carolina has begun making a prepandemic H5N1 flu vaccine and is ready to start producing vaccines for a real pandemic when needed, the company and federal health officials announced yesterday.
The facility in Holly Springs, N.C., billed as the first of its kind in the United States, was dedicated yesterday after a long testing process.
(CIDRAP News) If someone tried to kill Americans with Bacillus anthracis spores today, the nation would have a better medical tool chest for treating the sick and those potentially exposed than it had 10 years ago, when the anthrax letter attacks killed five people, but anthrax defenses are still a work in progress.
(CIDRAP News) Positioning supplies of antibiotics in communities has been proposed as the next step to prepare for a Bacillus anthracis attack, and state and local public health officials are in the best position to determine where and how they should be stored, an Institute of Medicine (IOM) expert group reported today.
(CIDRAP News) – Two companies recently received contracts to advance the development of countermeasures against Bacillus anthracis attacks, a next-generation vaccine given as a nasal spray and an injectable antitoxin, the US Department of Health and Human Services (HHS) announced today.
(CIDRAP News) – The US government's efforts to promote the development of new medical countermeasures (MCMs) against biological and other unconventional weapons are making headway, with more than 70 products now in development, a top Department of Health and Human Services (HHS) official told a House committee recently.